- Home
- IKT vs DLNG Comparison
IKT vs DLNG Comparison
Compare IKT & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- DLNG
- Stock Information
- Founded
- IKT 2008
- DLNG 2013
- Country
- IKT United States
- DLNG Greece
- Employees
- IKT N/A
- DLNG N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- DLNG Marine Transportation
- Sector
- IKT Health Care
- DLNG Consumer Discretionary
- Exchange
- IKT Nasdaq
- DLNG Nasdaq
- Market Cap
- IKT 140.5M
- DLNG 129.0M
- IPO Year
- IKT 2020
- DLNG 2013
- Fundamental
- Price
- IKT $1.71
- DLNG $3.61
- Analyst Decision
- IKT Buy
- DLNG
- Analyst Count
- IKT 2
- DLNG 0
- Target Price
- IKT $8.00
- DLNG N/A
- AVG Volume (30 Days)
- IKT 117.1K
- DLNG 33.6K
- Earning Date
- IKT 08-26-2025
- DLNG 09-09-2025
- Dividend Yield
- IKT N/A
- DLNG 5.41%
- EPS Growth
- IKT N/A
- DLNG 53.29
- EPS
- IKT N/A
- DLNG 1.10
- Revenue
- IKT N/A
- DLNG $157,455,000.00
- Revenue This Year
- IKT N/A
- DLNG N/A
- Revenue Next Year
- IKT N/A
- DLNG $0.37
- P/E Ratio
- IKT N/A
- DLNG $3.27
- Revenue Growth
- IKT N/A
- DLNG N/A
- 52 Week Low
- IKT $1.12
- DLNG $3.18
- 52 Week High
- IKT $4.20
- DLNG $5.65
- Technical
- Relative Strength Index (RSI)
- IKT 49.23
- DLNG 52.32
- Support Level
- IKT $1.42
- DLNG $3.56
- Resistance Level
- IKT $1.83
- DLNG $3.80
- Average True Range (ATR)
- IKT 0.15
- DLNG 0.10
- MACD
- IKT 0.00
- DLNG 0.01
- Stochastic Oscillator
- IKT 62.11
- DLNG 48.53
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.